Cellphire Therapeutics

Selected news for the company - Cellphire Therapeutics, collected since 4/2021. We are still establishing shared news links for this company.

Please provide a valid email address.
Shares Healthcare News With (link):
Other Healthcare Entities

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/5/2021 Cellphire Therapeutics closes $15M Series A drugdeliverybusiness.com Cellphire Therapeutics closes $15M Series A April 5, 2021 By Sean WhooleyLong-term stabilization and platelet storage product developer Cellphire Therapeutics announced that it closed a $15 million Series A financing round.Rockville, Md.-based Cellphire develops Thrombosomes and Cryopreserved Platelets (CPP) in bleeding patients. The former is a platelet-based, freeze-dried hemostatic agent, while CPP — frozen platelets — is being developed for the U.S. Army to ...
4/3/2021 The Ridgway Record ridgwayrecord.com ROCKVILLE, Md. , April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics , Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million Series A financing round led by Simcah Management.This Series A funding comes at an exciting time for Cellphire as it enters two Phase 2 clinical trials with two products, Thrombosomes® and Cryopreserved Platelets (CPP) in bleeding patients. The company's lead ...
4/2/2021 ROCKVILLE, Md. Cel wapakdailynews.com ROCKVILLE, Md. Cellphire Therapeutics , Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million Series A financing round led by Simcah Management.This Series A funding comes at an exciting time for Cellphire as it enters two Phase 2 clinical trials with two products, Thrombosomes® and Cryopreserved Platelets (CPP) in bleeding patients. The company's lead product, Thrombosomes®, is ...
4/2/2021 Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management | Markets Insider Business Insider ROCKVILLE, Md. , April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics , Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million Series A financing round led by Simcah Management. This Series A funding comes at an exciting time for Cellphire as it enters two Phase 2 clinical trials with two products, Thrombosomes® and Cryopreserved Platelets (CPP) in bleeding patients. The company's lead ...
4/2/2021 Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management continentalnewsshow.com Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management ROCKVILLE, Md., Cellphire Therapeutics , Inc., the global leader in long-term stabilization and storage of platelets, announced… ROCKVILLE, Md., Cellphire Therapeutics , Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million Series A financing round led by Simcah Management. This Series A funding comes at ...
4/2/2021 Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management vcaonline.com Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management Funding enables Cellphire to enhance its Thrombosomes® research and clinical development ROCKVILLE, Md., April 2, 2021-- Cellphire Therapeutics , Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million Series A financing round led by Simcah Management. This Series A funding comes at an exciting time ...